Yoshiyuki Suehara

Response to Cabozantinib in Patients with <i>RET</i> Fusion-Positive Lung Adenocarcinomas

Alexander Drilon, Lu Wang, Adnan Hasanovic et al. · Cancer Discovery · 2013 · 470 citations · Full text

Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer

Christine M. Lovly, Nerina T. McDonald, Heidi Chen et al. · Nature Medicine · 2014 · 265 citations · Full text

Medicine, Cancer Biology, Co-targeting Igf-1r +7

A method of high-throughput functional evaluation of <i>EGFR</i> gene variants of unknown significance in cancer

Shinji Kohsaka, Masaaki Nagano, Toshihide Ueno et al. · Science Translational Medicine · 2017 · 207 citations

Identification of <i>KIF5B-RET</i> and <i>GOPC-ROS1</i> Fusions in Lung Adenocarcinomas through a Comprehensive mRNA-Based Screen for Tyrosine Kinase Fusions

Yoshiyuki Suehara, Maria E. Arcila, Lu Wang et al. · Clinical Cancer Research · 2012 · 178 citations

Distinct clinicopathological features of NAB2-STAT6 fusion gene variants in solitary fibrous tumor with emphasis on the acquisition of highly malignant potential

Keisuke Akaike, Aiko Kurisaki‐Arakawa, Kieko Hara et al. · Human Pathology · 2014 · 142 citations · Full text